🔎 Trials Near Me

Почетна › Немалоклетни карцином плућа › Тексас › Houston

Kliničke studije za Немалоклетни карцином плућа u gradu Houston, TX

143 studija za Немалоклетни карцином плућа traži učesnike na lokacijama u gradu Houston i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

Тражи се учесникФаза 3
  • Oncology Consultants PA, Houston
  • University of Texas MD Anderson Cancer Center, Houston
Узраст од 18 до 100 · Оба пола · Ажурирано 13. 11. 2026. · NCT05920356

A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

Тражи се учесникФаза 1/2
  • Next Oncology - Houston, Houston
Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT07488676

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer

Тражи се учесникФаза 2
  • MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT07659782

A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)

Тражи се учесникФаза 1/2
  • University of Texas M. D. Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT07111520

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-based Chemotherapy With or Without Amivantamab for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

Тражи се учесникФаза 2/3
  • University of Texas MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07100080

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

Тражи се учесникФаза 3
  • The University of Texas MD Anderson Cancer Center Diagnostic Imaging, Houston
  • The University of Texas MD Anderson Cancer Center Investigational Pharmacy Services, Houston
  • The University of Texas, MD Anderson Cancer Center- Interventional Radiology, Houston
  • и још 3
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06758401

BostonGene and Exigent Genomic INsight Study

Тражи се учесникОпсервациона студија
  • Oncology Consultants, Houston
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06272864

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Тражи се учесникФаза 3
  • Houston Methodist Hospital, Houston
  • Houston Methodist West Hospital, Houston
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT04267848

A Phase 2 Platform Study of Immunomodulatory Compounds in ICI-refractory Non-small Cell Lung Cancer

Тражи се учесникФаза 2
  • MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07133425

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

Тражи се учесникФаза 1
  • University of Texas MD Anderson Cancer Center, Houston
  • NEXT Houston, Houston
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06270706

A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

Тражи се учесникФаза 3
  • Oncology Consultants P.A. ( Site 0113), Houston
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06345729

Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)

Тражи се учесникФаза 1
  • The University of Texas MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT04886804

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

Тражи се учесникФаза 1/2
  • MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT07020221

A Study of DS-3939a in Participants With Solid Tumors

Тражи се учесникФаза 1/2
  • The University of Texas Md Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT07739966

Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

Тражи се учесникФаза 2
  • The University of Texas MD Anderson Cancer Center, Houston
  • The University of Texas, MD Anderson Cancer Center - West Houston, Houston
Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT04557449

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

Тражи се учесникФаза 1
  • MD Anderson, Houston
  • NEXT Texas LLC - Houston, Houston
Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT07503808

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

Тражи се учесникФаза 3
  • Houston Methodist Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT06216301

A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

Тражи се учесникФаза 3
  • Houston Methodist Cancer Center ( Site 0191), Houston
  • MD Anderson Cancer Center ( Site 0150), Houston
  • Memorial Hermann Cancer Center ( Site 0172), Houston
  • и још 2
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT06623422

A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

Тражи се учесникФаза 3
  • University of Texas-MD Anderson Cancer Center ( Site 3283), Houston
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07513376

A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%

Тражи се учесникФаза 3
  • University of Texas MD Anderson Cancer Center, Houston
  • Local Institution - 0517, Houston
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT06561386

A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors

Тражи се учесникФаза 1
  • The University of Texas MD Anderson Cancer Center, Houston
Узраст од 18 до 99 · Оба пола · Ажурирано 6. 11. 2026. · NCT06983743

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Тражи се учесникФаза 3
  • Texas Oncology - Gulf Coast, Houston
  • The University of Texas MD Anderson Cancer Center Diagnostic Imaging, Houston
  • The University of Texas MD Anderson Cancer Center, Houston
  • и још 5
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07144280

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

Тражи се учесникФаза 1
  • University of Texas MD Anderson Cancer Center, Houston
  • The University of Texas, MD Anderson Cancer Center - West Houston, Houston
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07090499

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Тражи се учесникФаза 3
  • The University of Texas MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT06793215

A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation

Тражи се учесникФаза 1/2
  • MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT05789082

A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

Тражи се учесникФаза 3
  • The University of Texas-MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07361497

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Тражи се учесникФаза 1
  • University of Texas MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06465069

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

Тражи се учесникФаза 3
  • Kelsey-Seybold Clinic, Houston
  • Houston Methodist Hospital, Houston
  • University of Texas MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06890598

A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations

Тражи се учесникФаза 1/2
  • The University of Texas - M.D. Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06706076

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

Тражи се учесникФаза 1
  • The University of Texas - MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06400472

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

Тражи се учесникФаза 1/2
  • The University of Texas MD Anderson Cancer Center (site 127), Houston
Узраст од 18 до 80 · Оба пола · Ажурирано 4. 11. 2026. · NCT03556228

SI-B036-ST-101 in Advanced/Metastatic Solid Tumors

Тражи се учесникФаза 1
  • MD Anderson, Houston
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07857616

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Тражи се учесникФаза 3
  • Houston Methodist Hospital, Houston
  • University of Texas MD Anderson Cancer Center, Houston
  • Lumi Research, Houston
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06119581

Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors

Тражи се учесникФаза 1/2
  • MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07397338

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

Тражи се учесникФаза 2
  • MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06695845

Safety and Efficacy of OBX-115 in Advanced Solid Tumors

Тражи се учесникФаза 1/2
  • M.D. Anderson Cancer Center (Melanoma/NSCLC), Houston
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT06060613

A Phase 1 Study of IM-1617 in Participants With Advanced Cancer

Тражи се учесникФаза 1
  • MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07578571

A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)

Тражи се учесникФаза 2
  • MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT06667908

A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC

Тражи се учесникФаза 2
  • University of Texas MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT06010329

A Study of [225Ac]Ac-AKY-2519 in Patients With B7-H3 Expressing Solid Tumors

Тражи се учесникФаза 1
  • MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT07887971

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

Тражи се учесникФаза 3
  • The University of Texas MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT07185997

Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations

Тражи се учесникФаза 3
  • The University of Texas MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT07195695

Study of XB010 in Subjects With Solid Tumors

Тражи се учесникФаза 1
  • University of Texas MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT06545331

First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations

Тражи се учесникФаза 1/2
  • University of Texas MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT06043817

KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)

Тражи се учесникФаза 1/2
  • The University of Texas MD Anderson Cancer Center ( Site 0009), Houston
Узраст 18 и старији · Оба пола · Ажурирано 29. 10. 2026. · NCT04165070

DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

Тражи се учесникФаза 2
  • USA12-0, Houston
Узраст 18 и старији · Оба пола · Ажурирано 29. 10. 2026. · NCT06953089

KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)

Тражи се учесникОпсервациона студија
  • The University of Texas MD Anderson Cancer Center ( Site 0009), Houston
Узраст 18 и старији · Оба пола · Ажурирано 29. 10. 2026. · NCT04165798

Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers

Тражи се учесникФаза 1/2
  • Oncology Consultants, Houston
Узраст 18 и старији · Оба пола · Ажурирано 29. 10. 2026. · NCT05098132

Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]

Тражи се учесникФаза 3
  • Memorial Hermann Cancer Center ( Site 0015), Houston
  • Oncology Consultants P.A. ( Site 0124), Houston
Узраст 18 и старији · Оба пола · Ажурирано 29. 10. 2026. · NCT06422143

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

Тражи се учесникФаза 1
  • MD Anderson, Houston
Узраст 18 и старији · Оба пола · Ажурирано 29. 10. 2026. · NCT06774963

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

Тражи се учесникФаза 3
  • Research Site, Houston
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT06357533

A Study of MGC026 in Participants With Advanced Solid Tumors

Тражи се учесникФаза 1
  • The University of Texas MD Anderson Cancer Center, Houston
  • University of Texas Health Science Center at Houston, Houston
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT06242470

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

Тражи се учесникФаза 1
  • Research Site, Houston
Узраст 18 и старији · Оба пола · Ажурирано 26. 10. 2026. · NCT06835569

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Тражи се учесникФаза 2
  • The University of Texas MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 26. 10. 2026. · NCT06172478

Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer

Тражи се учесникФаза 3
  • University of Texas M. D. Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 23. 10. 2026. · NCT06899126

Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

Тражи се учесник
  • Michael E. DeBakey VA Medical Center, Houston, TX, Houston
Узраст 18 и старији · Оба пола · Ажурирано 23. 10. 2026. · NCT02984761

A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Тражи се учесникФаза 2
  • Local Institution - 0095, Houston
Узраст 18 и старији · Оба пола · Ажурирано 23. 10. 2026. · NCT07680764

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

Тражи се учесникФаза 3
  • Kelsey-Seybold Clinic Main Campus, Houston
Узраст 18 и старији · Оба пола · Ажурирано 23. 10. 2026. · NCT07361510

A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

Тражи се учесникФаза 2
  • The University of Texas MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 22. 10. 2026. · NCT07154290

A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors

Тражи се учесникФаза 1
  • The University of Texas MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 22. 10. 2026. · NCT07705334

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

Тражи се учесникФаза 2
  • Research Site, Houston
Узраст од 18 до 95 · Оба пола · Ажурирано 21. 10. 2026. · NCT05061550

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

Тражи се учесникФаза 1/2
  • MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 21. 10. 2026. · NCT06810544

Intratumoral N17350 in Advanced Solid Tumors

Тражи се учесникФаза 1/2
  • The University of Texas MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 21. 10. 2026. · NCT07339176

Study of PF-07248144 in Advanced or Metastatic Solid Tumors

Тражи се учесникФаза 2
  • The University of Texas M. D. Anderson Cancer Center, Houston
  • U.T. MD Anderson Cancer Center, Houston
  • MD Anderson West Houston, Houston
Узраст 18 и старији · Оба пола · Ажурирано 21. 10. 2026. · NCT04606446

A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

Тражи се учесникФаза 1/2
  • The University of Texas MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 19. 10. 2026. · NCT06244771

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

Тражи се учесникФаза 1/2
  • The University of Texas MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 19. 10. 2026. · NCT06162221

A Study of Novel Combinations in Non-Small Cell Lung Cancer (NSCLC)

Тражи се учесникФаза 2
  • Research Site, Houston
Узраст 18 и старији · Оба пола · Ажурирано 15. 10. 2026. · NCT07098338

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

Тражи се учесникФаза 1/2
  • MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 15. 10. 2026. · NCT06239194

SMP-3124LP in Adults With Advanced Solid Tumors

Тражи се учесникФаза 1/2
  • MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 15. 10. 2026. · NCT06526819

KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

Тражи се учесникФаза 1
  • MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 14. 10. 2026. · NCT06026410

A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC

Тражи се учесникФаза 1
  • MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 14. 10. 2026. · NCT07462377

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Тражи се учесникФаза 1/2
  • MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 13. 10. 2026. · NCT05786924

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

Тражи се учесникФаза 1/2
  • The University of Texas MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 9. 10. 2026. · NCT07070232

Honokiol in Early-Stage Resectable Non-Small Cell Lung Cancer

Тражи се учесникФаза 1
  • Houston Methodist Neal Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 8. 10. 2026. · NCT06566443

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Тражи се учесникФаза 3
  • Kelsey Research Foundation, Houston
  • Kelsey-Seybold Clinic - North Houston Campus, Houston
  • Texas Oncology - Gulf Coast, Houston
  • и још 5
Узраст 18 и старији · Оба пола · Ажурирано 8. 10. 2026. · NCT07222566

Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers

Тражи се учесникФаза 1/2
  • Southwest Oncology Associates, Houston
  • Lumi Research, Houston
Узраст 18 и старији · Оба пола · Ажурирано 8. 10. 2026. · NCT07227298

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

Тражи се учесникФаза 1/2
  • Research Site, Houston
Узраст 18 и старији · Оба пола · Ажурирано 8. 10. 2026. · NCT07115043

Couple-Based Meditation for Metastatic Lung Cancer Patients and Their Partners

Тражи се учесникЗдраве особе су добродошле
  • Memorial Hermann, Houston
  • University of Texas MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 6. 10. 2026. · NCT02596490

Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cell Lung or Esophageal Cancer Undergoing Radiotherapy and Their Caregivers

Тражи се учесникЗдраве особе су добродошле
  • M D Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 6. 10. 2026. · NCT03948100

A Study of ZW251 in Participants With Advanced Solid Tumors

Тражи се учесникФаза 1
  • MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 5. 10. 2026. · NCT07164313

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Тражи се учесникФаза 1/2
  • The University of Texas MD Anderson Cancer Center, Houston
Узраст 12 и старији · Оба пола · Ажурирано 2. 10. 2026. · NCT04585750

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

Тражи се учесникФаза 1
  • The University of Texas MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 1. 10. 2026. · NCT06625775

A Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC)

Тражи се учесникФаза 2
  • MD Anderson Cancer Hospital, Houston
Узраст 18 и старији · Оба пола · Ажурирано 1. 10. 2026. · NCT06907615

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

Тражи се учесникФаза 1/2
  • MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 1. 10. 2026. · NCT07189871

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

Тражи се учесникФаза 1
  • ALX Center 5, Houston
Узраст 18 и старији · Оба пола · Ажурирано 30. 9. 2026. · NCT07085091

A Study of PHN-012 in Patients With Advanced Solid Tumors

Тражи се учесникФаза 1
  • PHN-012-001 Site, Houston
Узраст 18 и старији · Оба пола · Ажурирано 29. 9. 2026. · NCT07127874

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

Тражи се учесникФаза 1
  • Research Site, Houston
Узраст 18 и старији · Оба пола · Ажурирано 29. 9. 2026. · NCT05877599

Ph1/2 Trial Of Navlimetostat With Pumitamig In MTAP-Deficient Advanced Non-Small Cell Lung Cancer

Тражи се учесникФаза 1/2
  • UT MD Anderson, Houston
Узраст 18 и старији · Оба пола · Ажурирано 25. 9. 2026. · NCT07579221

Dyadic Yoga Program for Patients Undergoing Thoracic Radiotherapy and Their Family Caregivers: The Testing of a Mobile Application Delivery

Тражи се учесник
  • The University of Texas M. D. Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 25. 9. 2026. · NCT06919874

Pan-tumor MRD Study

Тражи се учесникОпсервациона студија
  • Onocology Consultants P.A. (Oncology Consultants [OC Houston]), Houston
Узраст 18 и старији · Оба пола · Ажурирано 24. 9. 2026. · NCT06605404

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Тражи се учесникФаза 1/2
  • MD Anderson, Houston
Узраст 18 и старији · Оба пола · Ажурирано 22. 9. 2026. · NCT06128551

Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer

Тражи се учесникОпсервациона студија
  • Oncology Consultants, P.A., Houston
Узраст 18 и старији · Оба пола · Ажурирано 22. 9. 2026. · NCT07028489

An External Control Arm Study in Non-Small Cell Lung Cancer

Тражи се учесникОпсервациона студија
  • Oncology Consultants, Houston
Узраст 18 и старији · Оба пола · Ажурирано 22. 9. 2026. · NCT07174388

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

Тражи се учесникФаза 1/2
  • The University of Texas MD Anderson Cancer Center - Texas Medical Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 21. 9. 2026. · NCT07629960

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Тражи се учесникФаза 1
  • Oncology Consultants, P.A., Houston
  • University of Texas M.D. Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 21. 9. 2026. · NCT05983432

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

Тражи се учесникФаза 3
  • Clinical Study Site, Houston
Узраст 18 и старији · Оба пола · Ажурирано 18. 9. 2026. · NCT06767514

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Тражи се учесникФаза 1/2
  • MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 18. 9. 2026. · NCT05267626

A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

Тражи се учесникФаза 1
  • MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 17. 9. 2026. · NCT07020117

TT-4 and TT-10 as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors and Pleural Mesothelioma

Тражи се учесникФаза 1/2
  • The University of Texas MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 15. 9. 2026. · NCT04969315

Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers

Тражи се учесникФаза 2
  • MD ANDERSON CANCER CENTER (Data Collection Only), Houston
Узраст 18 и старији · Оба пола · Ажурирано 11. 9. 2026. · NCT04410796

A Phase 1/1b Study of IAM1363 in HER2 Cancers

Тражи се учесникФаза 1
  • MD Anderson Cancer Center - University of Texas, Houston
Узраст 18 и старији · Оба пола · Ажурирано 9. 9. 2026. · NCT06253871

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

Тражи се учесникФаза 1
  • Oncology Consultants Texas Medical Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 3. 9. 2026. · NCT06343402

Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion

Тражи се учесникФаза 1
  • MDACC, Houston
Узраст 18 и старији · Оба пола · Ажурирано 2. 9. 2026. · NCT05245500

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

Тражи се учесникФаза 1
  • MD Anderson, Houston
Узраст 18 и старији · Оба пола · Ажурирано 2. 9. 2026. · NCT04913285

FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

Тражи се учесникФаза 1
  • M. D. Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 2. 9. 2026. · NCT07216105

Study of FIH of STX-241 in Locally Advanced or Metastatic NSCLC Resistant to EGFR TKIs

Тражи се учесникФаза 1/2
  • Oncology Consultants (OC) - Texas Medical Center - Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 2. 9. 2026. · NCT06567015

Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer

Тражи се учесникФаза 3
  • Research Site, Houston
Узраст 18 и старији · Оба пола · Ажурирано 26. 8. 2026. · NCT06350097

A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer

Тражи се учесникФаза 1/2
  • MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 26. 8. 2026. · NCT06892548

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

Тражи се учесникФаза 1/2
  • Houston Methodist Hospital, Houston
Узраст 18 и старији · Оба пола · Ажурирано 17. 8. 2026. · NCT04895709

Predictive Biomarkers for Pneumonitis After Chemoradiotherapy and Immunotherapy in Patients With Non-small Cell Lung Cancer

Тражи се учесникОпсервациона студија
  • M D Anderson Cancer Center, Houston
Сви узрасти · Оба пола · Ажурирано 11. 8. 2026. · NCT04913311

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Тражи се учесникФаза 1/2
  • The University of Texas, MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 11. 8. 2026. · NCT05592626

Phase 1 Study Of Izalontamab Brengitecan + Adagrasib In NSCLC - The IZA-A Trial

Тражи се учесникФаза 1
  • The University of Texas M. D. Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 11. 8. 2026. · NCT07382726

Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors

Тражи се учесникФаза 1
  • NEXT - Oncology - Houston, Houston
Узраст 18 и старији · Оба пола · Ажурирано 5. 8. 2026. · NCT07444814

Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers

Тражи се учесникФаза 1
  • Uni Of TX MD Anderson Cancer Cntr, Houston
Узраст од 18 до 100 · Оба пола · Ажурирано 29. 7. 2026. · NCT06562192

Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer

Тражи се учесникФаза 1
  • MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 22. 7. 2026. · NCT05142189

A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

Тражи се учесникФаза 1
  • The University of Texas MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 22. 7. 2026. · NCT06131840

A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation

Тражи се учесникФаза 1
  • Md Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 22. 7. 2026. · NCT06179160

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

Тражи се учесникФаза 1
  • The University of Texas MD Anderson Cancer Center Investigational Pharmacy Services, Houston
  • The University of Texas MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 22. 7. 2026. · NCT05208762

A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.

Тражи се учесникФаза 1
  • Local Institution - 0049, Houston
Узраст 18 и старији · Оба пола · Ажурирано 20. 7. 2026. · NCT06476808

Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer

Тражи се учесникФаза 1
  • M D Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 15. 7. 2026. · NCT03819296

Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer

Тражи се учесникФаза 1
  • NEXT Houston, Houston
Узраст 18 и старији · Оба пола · Ажурирано 9. 7. 2026. · NCT07315113

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Тражи се учесникФаза 1
  • Oncology Consultants, PA, Houston
  • Oncology Consultants, PA., Houston
  • The University of Texas M.D. Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 6. 7. 2026. · NCT04389632

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

Тражи се учесникФаза 1
  • The University of Texas MD Anderson Cancer Center /ID# 270059, Houston
Узраст 18 и старији · Оба пола · Ажурирано 23. 6. 2026. · NCT05005403

A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors

Тражи се учесникФаза 1
  • MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 11. 6. 2026. · NCT06789172

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

Тражи се учесникФаза 1
  • University of Texas MD Anderson Cancer Center /ID# 252004, Houston
Узраст 18 и старији · Оба пола · Ажурирано 4. 6. 2026. · NCT04777994

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

Тражи се учесникФаза 1
  • University of Texas, MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 3. 6. 2026. · NCT06040541

BBO-11818 in Adult Subjects With KRAS Mutant Cancer

Тражи се учесникФаза 1
  • The University of Texas MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 2. 6. 2026. · NCT06917079

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Тражи се учесникФаза 1/2
  • MD Anderson Cancer Center, Houston
Узраст 12 и старији · Оба пола · Ажурирано 27. 5. 2026. · NCT03093116

Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)

Тражи се учесникФаза 3
  • MD Anderson, Houston
Узраст 18 и старији · Оба пола · Ажурирано 19. 5. 2026. · NCT07154706

Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)

Тражи се учесникФаза 1/2
  • The University of Texas MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 19. 5. 2026. · NCT05431270

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Тражи се учесникФаза 1/2
  • The University of Texas MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 15. 5. 2026. · NCT05379985

A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation

Тражи се учесникФаза 1/2
  • MD Anderson Cancer Center, Houston
Узраст од 18 до 75 · Оба пола · Ажурирано 24. 4. 2026. · NCT06385925

Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC

Тражи се учесникФаза 1
  • Research Site, Houston
Узраст 18 и старији · Оба пола · Ажурирано 13. 4. 2026. · NCT04686305

A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

Тражи се учесникФаза 1/2
  • MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 13. 4. 2026. · NCT06362369

A Study of VET3-TGI in Patients With Solid Tumors

Тражи се учесникФаза 1
  • University of Texas MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 7. 4. 2026. · NCT06444815

Repositioning Immunotherapy in VetArans With Lung Cancer

Тражи се учесникФаза 2
  • Michael E. DeBakey VA Medical Center, Houston, TX, Houston
Узраст 18 и старији · Оба пола · Ажурирано 2. 3. 2026. · NCT06275360

EZH2 Inhibitor, Tulmimetostat, and PD-1 Blockade for Treatment of Advanced Non-small Cell Lung Cancer

Тражи се учесникФаза 1/2
  • Michael E. DeBakey VA Medical Center, Houston, TX, Houston
Узраст 18 и старији · Оба пола · Ажурирано 27. 1. 2026. · NCT05467748

A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors

Тражи се учесникФаза 1
  • Oncology Consultants, Houston
Узраст 18 и старији · Оба пола · Ажурирано 12. 1. 2026. · NCT07181473

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

Тражи се учесникФаза 1/2
  • The University of Texas MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 11. 12. 2025. · NCT06943521

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Тражи се учесникОпсервациона студија
  • Massive Bio SYNERGY-AI site, Houston
Сви узрасти · Оба пола · Ажурирано 28. 10. 2025. · NCT03452774

A Study of NX-1607 in Adults With Advanced Malignancies

Тражи се учесникФаза 1
  • MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 9. 9. 2025. · NCT05107674

A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies

Тражи се учесникФаза 1/2
  • Oncology Consultants, P.A., Houston
  • The University of Texas M. D. Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 13. 2. 2025. · NCT05669430

A Study of IBI363 in Subjects with Advanced Solid Malignancies

Тражи се учесникФаза 2
  • MD Anderson Cancer Center-University of Texas, Houston
  • Oncology Consultants P.A., Houston
Узраст 18 и старији · Оба пола · Ажурирано 19. 12. 2024. · NCT06281678

Studije za Немалоклетни карцином плућа u drugim gradovima

Ostale studije u gradu Houston

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.